Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Connie B Newman

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Endocrinology and Metabolism Clinics of North America|August 13, 2022
Safety of Statins and Nonstatins for Treatment of DyslipidemiaConnie B Newman
Journal of Women'S Health (2002)|December 10, 2020
Mortality in COVID-19: Further Evidence for a Sex-Based Difference in the OpenSAFELY StudyConnie B Newman
Best Practice & Research. Clinical Endocrinology & Metabolism|June 2, 2022
Effects of endocrine disorders on lipids and lipoproteinsConnie B Newman
Endocrinology and Metabolism Clinics of North America|August 13, 2022
Update on Lipids and LipoproteinsConnie B Newman, Alan Chait
Annals of Internal Medicine|April 5, 2016
Management of Dyslipidemia for Cardiovascular Disease Risk ReductionJonathan A Tobert, Connie B Newman
Journal of Clinical Lipidology|February 20, 2016
Comment on the article by Moriarty et alConnie B Newman, Jonathan A Tobert
The Journal of Clinical Endocrinology and Metabolism|December 5, 2022
Targeting PCSK9 With Antibodies and Gene Silencing to Reduce LDL CholesterolConnie B Newman, Jonathan A Tobert
Journal of Clinical Lipidology|September 1, 2016
The nocebo effect in the context of statin intoleranceJonathan A Tobert, Connie B Newman
JAMA|March 11, 2015
Statin intolerance: reconciling clinical trials and clinical experienceConnie B Newman, Jonathan A Tobert
European Journal of Preventive Cardiology|August 31, 2015
Statin tolerability: In defence of placebo-controlled trialsJonathan A Tobert, Connie B Newman
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Endocrinology and Metabolism Clinics of North America|August 13, 2022
Safety of Statins and Nonstatins for Treatment of DyslipidemiaConnie B Newman
Journal of Women'S Health (2002)|December 10, 2020
Mortality in COVID-19: Further Evidence for a Sex-Based Difference in the OpenSAFELY StudyConnie B Newman
Best Practice & Research. Clinical Endocrinology & Metabolism|June 2, 2022
Effects of endocrine disorders on lipids and lipoproteinsConnie B Newman
Endocrinology and Metabolism Clinics of North America|August 13, 2022
Update on Lipids and LipoproteinsConnie B Newman, Alan Chait
Annals of Internal Medicine|April 5, 2016
Management of Dyslipidemia for Cardiovascular Disease Risk ReductionJonathan A Tobert, Connie B Newman
Journal of Clinical Lipidology|February 20, 2016
Comment on the article by Moriarty et alConnie B Newman, Jonathan A Tobert
The Journal of Clinical Endocrinology and Metabolism|December 5, 2022
Targeting PCSK9 With Antibodies and Gene Silencing to Reduce LDL CholesterolConnie B Newman, Jonathan A Tobert
Journal of Clinical Lipidology|September 1, 2016
The nocebo effect in the context of statin intoleranceJonathan A Tobert, Connie B Newman
JAMA|March 11, 2015
Statin intolerance: reconciling clinical trials and clinical experienceConnie B Newman, Jonathan A Tobert
European Journal of Preventive Cardiology|August 31, 2015
Statin tolerability: In defence of placebo-controlled trialsJonathan A Tobert, Connie B Newman
Pageof 3